Just a few days ago, Medtronic Spine is facing anti-kickback allegations for promoting a bone growth promoting device, Infuse (limited for use in the lower back) to physicians with methods not approved by the FDA. This device is used in the spine to promote bone growth, solely for application to the lower back. However, Medtronic had been urging and pushing physicians to implant Infuse in 1) the neck region, not approved by the FDA, as well as using 2) “off-label” methods not approved by the FDA. Having spent $210 million to doctors as well as editing journal articles on Infuse, they have tried hiding information in order for physicians to use their product. Consequently, this has led to many deaths and injuries due to surgeons implanting these devices in the neck region. After having faced allegations back in 2008 for bribing physicians into using their products, they have violated this pledge and will face harsher consequences.